NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Manage capital allocation effectively to enhance shareholder value | Capital allocation is mixed but improving. | Under Pressure | Further large unregistered equity sales diluting shareholders | Unregistered equity issuance confirmed vs no large dilutive sales target Cemtrex issued unregistered Series 1 Preferred Stock to pay 10% dividends, constituting a dilutive equity sale that breaks the capital allocation driver. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 recent quarters. Management funded acquisitions with cash on hand and issued approximately 609,000 shares following a 1-for-10 reverse stock split. Dividend on preferred stock paid in shares. Capital allocation shows mixed execution with equity issuances but disciplined acquisition funding. Delivery assessment Oct 24, 2026 |
Revenue grows to ~$9 million by Feb 2027 | A primary condition in CEMTREX INC's published investment case. The stated target is ~$9 million. | Intact | Revenue falls below $8 million by Feb 2027 | Revenue: $18.44M FY2026-Q3; GAAP. Published target: ~$9 million. Target period ends 2027-02-05; this observation covers 2026-Q3. Source published Aug 14, 202618,440,210 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q3 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 67778b60-4ffd-48be-9ad2-3f2439bc3d36. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 2 recent quarters. Management completed the acquisition of PES in 2026-Q3, expected to add $4 to $5 million revenue next twelve months, and acquired Invocon in 2026-Q1 for $7.06 million. The company has made three acquisitions this fiscal year and signed an LOI for another, indicating delivering progress on strategic acquisitions. Delivery assessment Oct 24, 2026 |
Complete strategic acquisitions to enhance capabilities | The company is actively completing strategic acquisitions, with several deals closed in 2026. | Intact | No further strategic acquisitions completed in next 4 quarters | 1 acquisition completed vs target of continued activity Form 8-K filed Sept 16, 2026 confirms completion of PES asset acquisition for $3.5M cash. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 2 recent quarters. Management completed the acquisition of PES in 2026-Q3, expected to add $4 to $5 million revenue next twelve months, and acquired Invocon in 2026-Q1 for $7.06 million. The company has made three acquisitions this fiscal year and signed an LOI for another, indicating delivering progress on strategic acquisitions. Delivery assessment Oct 24, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative, acquisition-led growth story rather than a proven durable compounder. The thesis is on watch: recent performance trails its industry cohort, and the evidence points to high risk and volatile management execution.
The valuation evidence calls CETX cheap versus peers, while the expectations gap is slightly negative. Model confidence is low, so that comparison is uncertain; valuation has also risen sharply in the recent period, and the priced-in assessment is tagged justified with low fragility.
Near term, weak recent performance and erratic earnings surprises leave meaningful risk around the next results, including the possibility of guidance cuts. Over the multi-year view, acquisitions and growth in Advanced Industrial Services add capability and revenue potential, but acquisition integration and mixed capital allocation remain important execution tests.
The thesis depends on management turning acquisitions into sustained growth while improving financial performance without further weakening capital allocation. Near-term conditions could also be affected by guidance, interest-rate changes, and earnings trends at large technology companies, though these are broader sector influences rather than CETX-specific proof.
Over the next one to three years, CETX’s case rests on acquisition-led expansion translating into stronger fundamentals; current evidence remains weak and execution risk is high. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.